STAT3 and breast carcinoma: Additionally, another study has demonstrated that phosphorylated STAT3 (p-STAT3) is a substrate of PTPRD, and that the downregulation of PTPRD enhances stemness and promotes migration and invasion via the Jak/STAT3 pathway in breast cancer [8].